DIAGNOS Inc. announces a three (3) year framework partnership agreement with the CHUM (Center Hospitalier de l'Université de Montréal) on AI projects applied to the early detection of various retinal diseases. The various algorithms developed by DIAGNOS will be used to analyze changes in retinal microcirculation and their impacts on the prevention of complications of cardiovascular disease. This agreement also supports our project to screen diabetic retinopathy with automatic detection assisted by artificial intelligence, launched in June 2018. As soon as sanitary conditions permit, the technological showcase will resume in the endocrinology (diabetes) and ophthalmology clinics of the CHUM, in order to complete its demonstration phase.